Intelligence Profile
Clinical Applications
Ashwagandha (Withania somnifera) has been investigated for several clinical applications, though the evidence base varies in quality and depth across different conditions.
Stress and Anxiety Management
The most established clinical application appears to be for stress and anxiety disorders. A completed Phase 2 clinical trial (NCT01311180) specifically examined ashwagandha's effects in patients with generalized anxiety disorder using Sensoril®, a standardized extract. Additional completed studies have evaluated multi-herb formulations containing ashwagandha for stress modulation and related symptoms (NCT05602389), as well as supplement combinations targeting stress and sleep (NCT06889584).
Sleep Support
Emerging clinical interest exists in ashwagandha's potential for sleep-related issues, with at least one completed trial examining its effects on sleep in combination with other supplements. However, specific efficacy data from these trials is not available in the provided evidence.
Neurological Conditions
Preclinical research suggests potential applications in neurodegenerative diseases. Laboratory studies have identified withanolide A, a key compound in ashwagandha, as an inhibitor of hIAPP (human islet amyloid polypeptide) aggregation, which may have implications for metabolic and neurological conditions. Review articles discuss ashwagandha among medicinal plants being investigated for Alzheimer's disease and other neurological conditions, though clinical validation remains limited.
Metabolic Applications
Some research has characterized the carbohydrate profiles of ashwagandha in the context of anti-diabetic medicinal plants, suggesting potential metabolic applications, though specific clinical efficacy data is not provided.
Safety Profile
A clinical study specifically focused on the safety of ashwagandha root extract has been conducted (NCT06261476), though results are not available in the current evidence base.
Important Note: While these applications show promise, the evidence quality and depth varies significantly. Most completed trials lack published results in the provided evidence, making it difficult to assess clinical efficacy definitively. Individuals considering ashwagandha should consult healthcare providers, particularly given ongoing safety assessments and potential interactions with medications.